Retail Prices of Drugs: Clear Insights on New Pricing Changes
Retail prices of drugs are now fixed by India’s NPPA for 34 new medications, impacting consumers and pharmacies alike.
Exploring the Unseen and Unheard
Retail prices of drugs are now fixed by India’s NPPA for 34 new medications, impacting consumers and pharmacies alike.
Drug price controls are jeopardizing medical innovation and access to new treatments.
USFDA approval Venetoclax marks a significant milestone for Alembic Pharmaceuticals.
Cancer drug price cap: Discover how recent changes impact pricing for patients and access to medications.
Evonile Pharma acquisition is a strategic step to enhance brand portfolio and market presence. Discover the implications and benefits.
Drug price caps are being sought in Karnataka for broader affordability beyond just cancer medicines.
Lupin FDA approval marks a significant milestone in pharmaceutical advancements with Phytonadione Injectable Emulsion.
DCGI approval colchicine tablets brings new hope for patients seeking effective treatment options.
FDA approval Mirum Pharma brings hope for patients with ultra-rare bone growth disorders.
Cancer drug overpricing raises serious concerns about affordability and ethics in healthcare. Discover the shocking details.